13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
December 4, 2024
genOway's presentation on Wednesday, December 4, 2024 | 1:30 p.m. GMT:
Presence of myeloid and lymphoid cells are key for translational tumor biology, efficacy and safety assessment in humanized mouse models
- Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Investigating human immune cell recruitment into tumor microenvironment
- Studying myeloid cell functionality and their contribution to translatable safety assessment of therapies
13th Tumour Models London Summit 2024, December 4-5, 2024
Get in touch about
Let us know how we can help
Oops! Something went wrong while submitting the form.